29-Jan-2007

BioProgress plc ('BioProgress') (AIM: BPRG; NASDAQ: BPRG), the specialty pharma and healthcare company and Magenta Oral Dose Design a business unit of FMC Corporation (‘FMC’) (NSYE: FMC) are pleased to confirm the finalisation of the restructuring agreements regarding the licensing of NRobe technology.

For more information please click here
Terms & Conditions Privacy Statement
Login